336 related articles for article (PubMed ID: 37212317)
21. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
23. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.
Campbell TB; Borok M; White IE; Gudza I; Ndemera B; Taziwa A; Weinberg A; Gwanzura L
Clin Infect Dis; 2003 May; 36(9):1144-51. PubMed ID: 12715309
[TBL] [Abstract][Full Text] [Related]
24. KSHV infection and the pathogenesis of Kaposi's sarcoma.
Ganem D
Annu Rev Pathol; 2006; 1():273-96. PubMed ID: 18039116
[TBL] [Abstract][Full Text] [Related]
25. Infection of KSHV and Interaction with HIV: The Bad Romance.
Qin J; Lu C
Adv Exp Med Biol; 2017; 1018():237-251. PubMed ID: 29052142
[TBL] [Abstract][Full Text] [Related]
26. Kaposi sarcoma herpesvirus viral load in bronchoalveolar lavage as a diagnostic marker for pulmonary Kaposi sarcoma.
Saberian C; Lurain K; Hill LK; Marshall V; Castro EMC; Labo N; Miley W; Moore K; Roshan R; Ruggerio M; Ryan K; Widell A; Ekwede I; Mangusan R; Rupert A; Barochia A; Whitby D; Yarchoan R; Ramaswami R
AIDS; 2024 Jul; 38(8):1172-1180. PubMed ID: 38564482
[TBL] [Abstract][Full Text] [Related]
27. Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies.
Patel R; Lurain K; Yarchoan R; Ramaswami R
Expert Rev Anti Infect Ther; 2023; 21(9):929-941. PubMed ID: 37578202
[TBL] [Abstract][Full Text] [Related]
28. Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study.
Goedert JJ; Martin MP; Vitale F; Lauria C; Whitby D; Qi Y; Gao X; Carrington M
J Infect Dis; 2016 Feb; 213(3):432-8. PubMed ID: 26268853
[TBL] [Abstract][Full Text] [Related]
29. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.
Gramolelli S; Schulz TF
J Pathol; 2015 Jan; 235(2):368-80. PubMed ID: 25212381
[TBL] [Abstract][Full Text] [Related]
30. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not.
Quinlivan EB; Zhang C; Stewart PW; Komoltri C; Davis MG; Wehbie RS
J Infect Dis; 2002 Jun; 185(12):1736-44. PubMed ID: 12085319
[TBL] [Abstract][Full Text] [Related]
31. Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute
Oluoch PO; Forconi CS; Oduor CI; Ritacco DA; Akala HM; Bailey JA; Juliano JJ; Ong'echa JM; Münz C; Moormann AM
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047683
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS.
Chang Y; Moore PS
Infect Agents Dis; 1996 Oct; 5(4):215-22. PubMed ID: 8884366
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases.
Asahi-Ozaki Y; Sato Y; Kanno T; Sata T; Katano H
J Infect Dis; 2006 Mar; 193(6):773-82. PubMed ID: 16479510
[TBL] [Abstract][Full Text] [Related]
35. Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma.
Santiago JC; Goldman JD; Zhao H; Pankow AP; Okuku F; Schmitt MW; Chen LH; Hill CA; Casper C; Phipps WT; Mullins JI
PLoS Pathog; 2021 Jan; 17(1):e1008594. PubMed ID: 33465147
[TBL] [Abstract][Full Text] [Related]
36. Systematic analysis of Kaposi's sarcoma (KS)-associated herpesvirus genomes from a KS case-control study in Cameroon: Evidence of dual infections but no association between viral sequence variation and KS risk.
Marshall VA; Fisher NC; Goodman CA; Cornejo Castro EM; Liu I; Khanal S; Holdridge BM; Thorpe AL; Labo N; Stolka KB; Hemingway-Foday JJ; Abassora M; N'Dom P; Smith JS; Sallah N; Palser AL; Kellam P; Keele BF; Whitby D
Int J Cancer; 2022 Oct; 151(7):1127-1141. PubMed ID: 35608873
[TBL] [Abstract][Full Text] [Related]
37. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
McAllister SC; Moses AV
Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
[TBL] [Abstract][Full Text] [Related]
38. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
39. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma.
Kamiyango W; Villiera J; Silverstein A; Peckham-Gregory E; Campbell LR; El-Mallawany NK
Cancer Metastasis Rev; 2019 Dec; 38(4):749-758. PubMed ID: 31845111
[TBL] [Abstract][Full Text] [Related]
40. Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study.
Marshall V; Martró E; Labo N; Ray A; Wang D; Mbisa G; Bagni RK; Volfovsky N; Casabona J; Whitby D;
J Infect Dis; 2010 Oct; 202(7):1126-35. PubMed ID: 20715927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
